First Eagle Investment Management, LLC

Q3 2023 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
9/30/2023
Date filed
11/8/2023
Form type
13F-HR
Num holdings
524
Total value ($000)
$38,650,391
Net value change ($000)
-455,235 (-1.2%)
New positions
37
Sold out positions
23
Turnover %
1.8%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
DIS 326,171 NEW
SLB 227,527 17.0%
NOV 174,286 29.4%
EXR 160,856 191495.2%
IMO 136,033 11.1%
XOM 121,492 8.5%
OKE 110,047 NEW
FNF 86,768 54.7%
CMCSA 69,853 5.2%
GOOGL 64,256 7.9%
Top Reduces (Value $000, Stocks/ETFs)
HCA -274,152 -19.8%
ORCL -264,103 -11.8%
ABEV -191,157 -19.3%
UHS -155,666 -21.1%
IPGP -151,030 -25.9%
UNP -145,807 -99.1%
TSM -133,794 -14.6%
NEM -111,691 -14.2%
B -104,013 -14.5%
CHRW -93,953 -10.4%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 552,900 (1.4% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 FIRST EAGLE SEPARATE ACCOUNT MANAGEMENT, LLC 028-22867